Nausea, diarrhea, constipation, and reduced appetite are the most common
regarding weight, retatrutide achieved a maximum reduction of 16.9%, dulaglutide 2%, and the placebo group 3%
You can also report suspected side effects directly to the MHRA via the Yellow Card Scheme at yellowcard
The goal is preserving the strength, muscle mass, movement quality, bone health, and resilience that allow women to continue doing the things they love long after the weight loss phase is over
J Leukoc Biol 77: 7
High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome